![](/img/cover-not-exists.png)
OI-A-1Pharmacokinetic/pharmacodynamic (PK/PD) model for tolvaptan (TOL) in patients with congestive heart failure (CHF) and/or hyponatremia (HYP).
VANWART, S, CIRINCIONE, B, LUDWIG, E, CHEN, X, SHOAF, S, GRASELA, T, MALLIKAARJUN, SVolume:
79
Language:
english
Pages:
1
Journal:
Clinical Pharmacology & Therapeutics
DOI:
10.1016/j.clpt.2005.12.002
Date:
February, 2006
File:
PDF, 41 KB
english, 2006